Automated topic entity

Rapamycin

Research concerning mTOR inhibition, rapalogs, ageing biology, and human translation.

Entity typetopic
Published records23

Research

  1. EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.September 10, 2026 · 75% match confidence
  2. Rapamycin Alleviates Age-Related Senescence in Human Facial Dermal Fibroblasts by Modulating AutophagySeptember 10, 2026 · 75% match confidence

Clinical trials

  1. Everolimus Aging StudySeptember 4, 2026 · 80% match confidence
  2. A Study of Exercise and Pharmacologic Intervention on Systemic InflammationAugust 27, 2026 · 68% match confidence
  3. The Role of Sirolimus in Preventing Functional Decline in Older AdultsJune 25, 2026 · 80% match confidence
  4. MTOR Inhibitors in Older AdultsJune 25, 2026 · 80% match confidence
  5. RESTOR: PK/PD mTORi Inhibition in Older AdultsJune 1, 2026 · 68% match confidence
  6. Rapalog Pharmacology (RAP PAC) StudyMay 28, 2026 · 80% match confidence
  7. Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal WomenApril 7, 2026 · 80% match confidence
  8. Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal WomenApril 6, 2026 · 80% match confidence
  9. Combination Gerotherapeutic Interventions for Healthspan ImprovementMarch 16, 2026 · 68% match confidence
  10. Effect of Rapamycin in Ovarian AgingDecember 26, 2025 · 80% match confidence
  11. Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function]October 8, 2025 · 68% match confidence
  12. The Bioavailability of Compounded and Generic Rapamycin in Normative Aging IndividualsAugust 13, 2024 · 80% match confidence
  13. Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity StudyJanuary 24, 2024 · 80% match confidence
  14. Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR StudyJanuary 9, 2024 · 68% match confidence
  15. A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With PrediabetesDecember 11, 2023 · 80% match confidence
  16. Aging Mammary Stem Cells and Breast Cancer PreventionDecember 5, 2023 · 68% match confidence
  17. VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional SupplementsJune 7, 2022 · 80% match confidence
  18. mTOR and Adipose Tissue InflammationAugust 14, 2019 · 68% match confidence
  19. Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial CancerJuly 23, 2019 · 80% match confidence
  20. Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the ElderlyDecember 4, 2018 · 68% match confidence
  21. Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) TrialDecember 7, 2016 · 80% match confidence